Vascular Dementia

doi:10.1017/9781108593946.008

Chapter 7 - Vascular Dementia

Published online by Cambridge University Press: 21 June 2019

Naji Tabet and

Gosia Raczek

Edited by

Rob Butler and

Cornelius Katona

Show author details

Rob Butler: Affiliation:
Waitemata DHB and North Shore Hospital, Auckland
Cornelius Katona: Affiliation:
Helen Bamber Foundation

Book contents

Get access

Summary

Historically, the presence of vascular risk factors with imaging evidence of cerebral ischaemic/small vessel changes pointed towards a diagnosis of vascular dementia (VaD). This certainty, however, has been challenged by more recent evidence linking cerebrovascular risk factors readily attributed to VaD with the pathogenesis of Alzheimer’s disease (AD). Further diagnostic complication relates to the fact that the presence of cerebrovascular disease can also be encountered in other dementias and in those with no cognitive impairment. In one UK naturalistic memory clinic study, for example, more than 80% of patients diagnosed with AD (mean Hachinski Ischemic score < 1) had some evidence of cerebrovascular disease reported on their magnetic resonance imaging (MRI) brain scans [1]. Notwithstanding the challenges faced in diagnosing VaD and the heterogeneous nature of the disorder, it is universally recognised that VaD is probably the second most common type of dementia after AD and remains a major public health problem [2].

Type: Chapter
Information: Seminars in Old Age Psychiatry , pp. 79 - 87

DOI: https://doi.org/10.1017/9781108593946.008 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Tabet, N., Quinn, R., Klugman, A. (2009) ‘Prevalence and cognitive impact of cerebrovascular findings in Alzheimer’s disease: A retrospective, naturalistic study’. Int J Clin Pract 63: 338–45.Google Scholar

Gorelick, P. B., Scuteri, A., Black, S. E., et al. (2011) ‘Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American Heart Association/American Stroke Association’. Stroke 42: 2672–713.Google Scholar

Yang, T., Sun, Y., Lu, Z., et al. (2017) ‘The impact of cerebrovascular aging on vascular cognitive impairment and dementia’. Ageing Res Rev 34: 15–29.Google Scholar

Prins, N. D., Scheltens, P. (2015) ‘White matter hyperintensities, cognitive impairment and dementia: An update’. Nat Rev Neurol 11: 157–65.Google Scholar

Popescu, B. O., Toescu, E. C., Popescu, L. M., et al. (2009) ‘Blood-brain barrier alterations in ageing and dementia’. J Neurol Sci 283: 99–106.Google Scholar

Harris, J. J., Attwell, D. (2012) ‘The energetics of CNS white matter’. J Neurosci 32: 356–71.CrossRef Google Scholar PubMed

Garcia, P. Y., Roussel, M., Bugnicourt, J. M., et al. (2013) ‘Cognitive impairment and dementia after intracerebral hemorrhage: A cross-sectional study of a hospital-based series’. J Stroke Cerebrovasc Dis 22: 80–6.Google Scholar

Hachinski, V. C., Lassen, N. A., Marshall, J. (1974) ‘Multi-infarct dementia – Cause of mental deterioration in the elderly’. Lancet 2: 207–10.Google Scholar

Roman, G. C., Ekrjuntii, T., Wallin, A., et al. (2002) ‘Subcortical ischaemic vascular dementia’. Lancet Neurology 1: 426–36.Google Scholar

Roman, G. C., Tatemichi, T. K., Erkinjuntti, T., et al. (1993) ‘Vascular dementia: Diagnostic criteria for research studies: Report of the NINDS-AIREN International Workshop’. Neurology 43: 250–60.Google Scholar

O’Brien, J. T., Thomas, A. (2015) ‘Vascular dementia’. Lancet 386: 1698–706.Google Scholar

Hachinski, V. C. (1994) ‘Vascular dementia – A radical redefinition’. Dementia 5: 130–2.Google Scholar

Scrobot, O. A., Black, S. E., Chen, C., et al. (2017) ‘Progress towards standardised diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment in Cognition Classification Consensus Study’. Alzheimers Dement 14(3): 280–92.Google Scholar

Jorm, A. F., Jolley, D. (1998) ‘The incidence of dementia: A meta-analysis’. Neurology 51: 728–33.Google Scholar

Barbay, M., Taillia, H., Nedelec-Ciceri, C., et al. (2017) ‘Vascular cognitive impairment: Advances and trends’. Rev Neurol (Paris) 173: 473–80.CrossRef Google Scholar PubMed

Kalaria, R. N. (2010) ‘Vascular basis for brain degeneration: Faltering controls and risk factors for dementia’. Nutr Rev 68(Suppl 2): S74–S87.Google Scholar

Ikram, M. A., Bersano, A., Manso-Calderón, R., et al. (2017) ‘Genetics of vascular dementia – Review from the ICVD working group’. BMC Med 15: 48.Google Scholar

Stefanova, E., Pavlovic, A., Jovanovic, Z., et al. (2012) ‘Vascular risk factors in Alzheimer’s disease – Preliminary report’. J Neurol Sci 322: 166–9.Google Scholar

Hoffmann, M. (2013) ‘The human frontal lobes and frontal network systems: An evolutionary, clinical, and treatment perspective’. ISRN Neurol: 892459.Google Scholar

Korczyn, A. D., Vakhapova, V., Grinberg, L. T. (2012) ‘Vascular dementia’. J Neurol Sci 322: 2–10.Google Scholar

Matthews, F. E., Brayne, C., Lowe, J., et al. (2009) ‘Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study’. PLoS Med 6: e1000180.Google Scholar

Wahlund, L. O., Barkhof, F., Fazekas, F., et al. (2001) ‘A new rating scale for age-related white matter changes applicable to MRI and CT’. Stroke 32: 1318–22.Google Scholar

Ashby-Mitchell, K., Burns, R., Shaw, J., Anstey, K. J. (2017) ‘Proportion of dementia in Australia explained by common modifiable risk factors’. Alzheimers Res Ther 9: 11.Google Scholar

Rakesh, G., Szabo, S. T., Alexopoulos, G. S., Zannas, A. S. (2017) ‘Strategies for dementia prevention: Latest evidence and implications’. Ther Adv Chronic Dis 8: 121–36.Google Scholar

Farina, N., Rusted, J., Tabet, N. (2014) ‘The effect of exercise interventions on cognitive outcome in Alzheimer’s disease: A systematic review’. Int Psychogeriatr 26: 9–18.Google Scholar

Wilkinson, D., Róman, G., Salloway, S., et al. (2010) ‘The long-term efficacy and tolerability of donepezil in patients with vascular dementia’. Int J Geriatr Psychiatry 25: 305–13.Google Scholar

Kandiah, N., Pai, M. C., Senanarong, V., et al. (2017) ‘Rivastigmine: The advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia’. Clin Interv Aging 12: 697–707.CrossRef Google Scholar PubMed

Erkinjuntti, T., Kurz, A., Gauthier, S., et al. (2002) ‘Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: A randomised trial’. Lancet 359: 1283–90.Google Scholar

Orgogozo, J. M., Rigaud, A. S., Stöffler, A., et al. (2002) ‘Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized, placebo-controlled trial (MMM 300)’. Stroke 33: 1834–9.CrossRef Google Scholar PubMed

Rouch, L., Cestac, P., Hanon, O., et al. (2015) ‘Antihypertensive drugs, prevention of cognitive decline and dementia: A systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms’. CNS Drugs 29: 113–30.Google Scholar

Book contents

Chapter 7 - Vascular Dementia

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive